Keymed, Biosciences Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis 07.08.2025 - 18:06:50 Keymed Biosciences Inc. New York China View original content:https://www.prnewswire.co.uk/news-releases/keymed-biosciences-announces-approval-of-stapokibart-for-the-treatment-of-seasonal-allergic-rhinitis-302371683.html
